Compounds > oxybutynin

oxybutynin and olanzapine

oxybutynin has been researched along with olanzapine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (83.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Aggarwal, G; Dhawan, S; HariKumar, SL	1
Fang, L; Li, N; Liu, C; Liu, X; Quan, P; Wan, X	1
Banga, AK; Vora, D	1

Reviews

1 review(s) available for oxybutynin and olanzapine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for oxybutynin and olanzapine

Article	Year
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation. Current drug delivery, 2012, Volume: 9, Issue:2 Topics: Administration, Cutaneous; Animals; Benzodiazepines; Biological Availability; Biological Products; Chemistry, Pharmaceutical; Excipients; Female; Male; Mice; Oils; Olanzapine; Permeability; Rabbits; Rats; Rats, Wistar; Skin; Skin Absorption; Transdermal Patch	2012
Mechanistic insights of the enhancement effect of sorbitan monooleate on olanzapine transdermal patch both in release and percutaneous absorption processes. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017, Sep-30, Volume: 107 Topics: Animals; Benzodiazepines; Calorimetry, Differential Scanning; Drug Liberation; Hexoses; Hydrogen Bonding; Male; Molecular Docking Simulation; Olanzapine; Rats, Wistar; Rheology; Skin; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Transdermal Patch	2017
Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine. Expert opinion on drug delivery, 2022, Volume: 19, Issue:11 Topics: Acrylates; Adhesives; Administration, Cutaneous; Drug Delivery Systems; Humans; Male; Olanzapine; Oleic Acid; Permeability; Pharmaceutical Preparations; Prostate-Specific Antigen; Silicones; Skin; Skin Absorption; Transdermal Patch	2022